Osteoporosis Drugs Market – Strategies, Share, Segmentation, In-Depth Analysis Research Report By Foresight To (2022-2031)
Global Osteoporosis Drugs Market: Forecast up to 2031
[70 pages report] This market research report includes a detailed segmentation of the global osteoporosis drugs market – by drug class (Bisphosphonates, Parathyroid Hormone Therapy, Selective Estrogen Receptor Modulator, RANK Ligand Inhibitors, Biosimilars, and Others), and by Regions (North America, Europe, Asia Pacific, and Rest of the World).
Access Free PDF With Graphs and Charts : https://www.sdki.jp/sample-request-107517
Overview of the Global Osteoporosis Drugs Market Research:
Infoholic’s market research report predicts that the global osteoporosis drugs market will grow at a CAGR of 4.3% during the forecast period. Osteoporosis or porous bone or thinning bones is a disease associated by low bone mass and bone tissue structural deterioration, resulting in bone fragility and enhanced risk of fractures of the spine, hip and wrist. It mainly effects elderly population, especially women who have already experienced menopause.
Upsurge in the prevalence of osteoporosis in postmenopausal women, increase in aging population, and increasing awareness among public about osteoporosis care are some of the important factors driving the market growth. Aging population is major risk factor for the development of osteoporosis, nearly 9.9 million people live with osteoporosis in US and an additional 43.1 million have low bone mineral density (BMD). However, expiration of the patents and side-effects associated with the drugs such as nausea, difficulty in swallowing, heartburn, and gastric ulcer are some of the factors that may prove detrimental for the market.
Growing investment in R&D for drug discovery and development and rising healthcare expenditure is anticipated to enhance the revenue of osteoporosis drugs market in next five years.
International Osteoporosis Foundation estimates that around 200 million individuals globally suffer from osteoporosis disease. Currently, it is estimated that over 200 million people worldwide suffer from this disease. Nearly 30% of all postmenopausal women have osteoporosis in the US and in Europe. According to National Institute of Health, about 53 million individuals in US either suffer from osteoporosis or at an increased risk due to low bone mass. The increasing patient base for osteoporosis diseases ensures constant growth of the market during the forecast period 2022 to 2031.
Request Sample For More Insights : https://www.sdki.jp/sample-request-107517
The industry generates majority of the revenue by the key players operating in this market few of them include Amgen, Inc., Eli Lilly & Company Ltd., Novartis AG, Pfizer Inc., Radius Health, Inc., and Merck & Co.
According to Infoholic Research analysis, North America accounted for the largest share of the global osteoporosis drugs market in 2018 and will retain a high position during the forecast period. North America is followed by Europe with a share of more than 20% of the global market in 2018.
Distributed Control Systems in Power Market Size, Latest Trends and Key Drivers Supporting Growth Forecast 2022-2031
Digital Video Recorder Market 2022 Future Business Analysis, Competitive Landscape, Segments, Sales, Supply, Demand and Forecast to 2031
Diode Mount Market Analysis By Size, Share Trends, Future Growth, Emerging Trends, Qualitative Outlook, Forecast To 2031
DIN Rail Industry PC Market Size by Type, By Distribution Channel, And Forecast till 2022-2031
Disconnect Switches Market Research Growth, Regions, Type and Application, Forecast Analysis to 2022-2031